Viewing StudyNCT00028288



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00028288
Status: COMPLETED
Last Update Posted: 2012-03-13
First Post: 2001-12-19

Brief Title: Study of Daclizumab in Patients With Chronic Persistent Asthma
Sponsor: Facet Biotech
Organization: Facet Biotech

Conditions & Keywords Data

Conditions:
Name
Asthma
Keywords:
Name View
Zenapax View
Asthma View
Daclizumab View
anti-Tac monoclonal antibody View
anti-IL-2 View